danibowman

About danibowman

This author has not yet filled in any details.
So far danibowman has created 2 blog entries.

Opinion: An economist’s change of heart: It’s time to regulate the prescription-drug middlemen

Pharmacy-benefit managers find ways to boost their bottom line at the expense of employers and patients I’ve studied the drug supply chain for years. Like many economists, I saw pharmacy-benefit managers (PBMs) as valuable actors in restraining drug prices, particularly when they went to bat for employer-based health plans. I’ve had a change of heart. [...]

Opinion: An economist’s change of heart: It’s time to regulate the prescription-drug middlemen2019-05-02T10:04:22-07:00

AMA: CVS-Aetna Merger Would Reduce PBM Competition, Raise Prices

The AMA is strongly opposed to the pending merger between CVS Health and Aetna, citing the potential for anticompetitive pharmacy benefit management practices. August 08, 2018 - The American Medical Association is urging the Department of Justice to squash the proposed merger between CVS Health and Aetna. The combined entity would drastically reduce competition in many [...]

AMA: CVS-Aetna Merger Would Reduce PBM Competition, Raise Prices2019-05-02T11:55:04-07:00